Ceftazidime

Product NDC: 0781-3178
11-digit product format: 007813178
Labeler code: 0781
Product ID: 0781-3178_f855e6f8-527b-4534-94f8-a97ceafdaa31
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Ceftazidime
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Labeler: Sandoz Inc
Application: ANDA062640
Marketing category: ANDA
Marketing start: 2008-05-15
Marketing end: 0000-00-00
Substance: CEFTAZIDIME
Active strength: 2 g/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0781-3178		D	Discontinued by firm		2026-08-03
excluded package	package	0781-3178	0781-3178-95	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 26 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0781-3178-95	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0781-3178-95	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0781-3178-95	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0781-3178-95	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0781-3178-95	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0781-3178-95	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0781-3178-95	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0781-3178-95	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0781-3178-95	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0781-3178-95	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0781-3178-95	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0781-3178-95	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	0781-3178-95	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A062640-001	CEFTAZIDIME	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20
A062640-002	CEFTAZIDIME	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20
A062640-003	CEFTAZIDIME	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20
A062640-004	CEFTAZIDIME	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A062640-002	AP
A062640-003	AP
A062640-004	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062640-001	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION			1985-11-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062640-002	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062640-003	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	1985-11-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062640-004	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	RS	1992-02-03	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062640-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062640-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062640-004	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062640-004	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062640-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062640-003	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062640-004	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-003	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062640-004	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-003	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062640-004	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-003	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062640-004	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-003	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062640-004	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-003	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062640-004	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-003	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062640-004	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062640-002	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062640-003	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062640-004	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062640-002	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062640-003	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062640-004	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062640-002	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062640-003	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062640-004	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062640-002	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062640-003	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062640-004	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062640-002	AP	1	`8072bd15b7f6…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0781-3178-95	2020-09-10	C162847	48780-1	9d75b9d1-28bf-f424-e053-dadaa90a57ce	Ceftazidime for Injection, USP
0781-3178-95	2020-01-31	C162847	48780-1	9d75b9d1-28bf-f424-e053-dadaa90a57ce	Ceftazidime for Injection, USP

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0781-3178-91	EA - Each	0781-3178	dd11cfdb-966d-42db-a24c-01ddf8ed2a11	1	2013-02-13
0781-3178-95	EA - Each	0781-3178	38cc71e0-1e5a-491f-9143-71b0ea1e5096	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFTAZIDIME	ACTIVE INGREDIENT	9M416Z9QNR	CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SANDOZ INC]	12
CEFTAZIDIME ANHYDROUS	ACTIVE MOIETY	DZR1ENT301	CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SANDOZ INC]	12
SODIUM CARBONATE	INACTIVE INGREDIENT	45P3261C7T	CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SANDOZ INC]	12

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ceftazidime	CEFTAZIDIME	WG Critical Care, LLC	22d6534c-4488-48a1-8d78-e2fb908259de	2026-06-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062640 application number: ANDA062640
Ceftazidime	CEFTAZIDIME	Sagent Pharmaceuticals	aec64360-8452-4987-a366-a5a4f8762ab6	2024-01-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062640 application number: ANDA062640
Ceftazidime	CEFTAZIDIME	WG Critical Care, LLC	bcc81df2-20e3-4738-bfcf-301da883c1d9	2023-09-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062640 application number: ANDA062640
Ceftazidime	CEFTAZIDIME	Sagent Pharmaceuticals	112c5457-8d71-49f5-b531-9761d7d38c93	2020-10-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062640 application number: ANDA062640